Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 71.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 197.50
  • 52 Week Low: 62.50
  • Currency: UK Pounds
  • Shares Issued: 105.33m
  • Volume: 16,619
  • Market Cap: 75.31m
  • RiskGrade: 697

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.9  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 n/a (2.81) (35.51)p n/a n/a n/a n/a 0.0%
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (750.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (25.20) (23.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (24.72) (21.26)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (29.40) (20.66)p n/a n/a n/a n/a 0.0%
31-Dec-20 28.92 (41.45) (15.79)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Verona Pharma Company Announcements

Verona Pharma Reports Encouraging Top-Line Data ... 14-Jan-2019 07:00 GlobeNewswire NA
Verona Pharma Receives WHO Approval for “e... 09-Jan-2019 13:00 GlobeNewswire NA
Verona Pharma Initiates Phase 2 Clinical Trial t... 17-Dec-2018 17:20 GlobeNewswire NA

Latest Verona Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 71.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 197.50
52 Week Low 62.50
Volume 16,619
Shares Issued 105.33m
Market Cap 75.31m
RiskGrade 697

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.68% below the market average0.68% below the market average0.68% below the market average0.68% below the market average0.68% below the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average
Price Trend
80.11% below the market average80.11% below the market average80.11% below the market average80.11% below the market average80.11% below the market average
42.37% below the sector average42.37% below the sector average42.37% below the sector average42.37% below the sector average42.37% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Verona Pharma Dividends

No dividends found

Trades for 21-Jan-2019

Time Volume / Share Price
16:39 2,500 @ 68.00p
12:59 1,500 @ 68.35p
12:40 4,597 @ 71.15p
12:38 4,597 @ 68.15p
12:16 1,392 @ 71.80p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Piers Morgan

Top of Page